Gilead Sciences, Inc. (GILD)
USD 90.69
(-2.27%)
USD 90.69
(-2.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8 Billion | 9.07 Billion | 11.38 Billion | 8.16 Billion | 9.14 Billion | 8.4 Billion |
| Net Income | 5.61 Billion | 4.56 Billion | 6.2 Billion | 89 Million | 5.36 Billion | 5.46 Billion |
| Depreciation & Amortization | 2.69 Billion | 2.1 Billion | 2.05 Billion | 1.48 Billion | 1.4 Billion | 1.42 Billion |
| Deferred income taxes | -962 Million | -1.55 Billion | -116 Million | -214 Million | -2.09 Billion | 289 Million |
| Stock-based compensation | 795 Million | 637 Million | 635 Million | 643 Million | 636 Million | 845 Million |
| Change in working capital | -2.3 Billion | -1.76 Billion | 489 Million | -1.63 Billion | -798 Million | -939 Million |
| Other non-cash items | 2.19 Billion | 5.08 Billion | 2.12 Billion | 7.8 Billion | 4.63 Billion | 1.31 Billion |
| Investing Cash Flow | -2.26 Billion | -2.46 Billion | -3.13 Billion | -14.61 Billion | -7.81 Billion | 14.35 Billion |
| Investments in PPE | -585 Million | -728 Million | -579 Million | -650 Million | -825 Million | -924 Million |
| Acquisitions | -1.15 Billion | -1.79 Billion | -1.4 Billion | -25.74 Billion | 825 Million | 346 Million |
| Investment purchases | -2.37 Billion | -1.94 Billion | -3.89 Billion | -20.77 Billion | -32.22 Billion | -10.57 Billion |
| Sales/Maturities of investments | 1.84 Billion | 2 Billion | 2.91 Billion | 32.71 Billion | 29.92 Billion | 25.85 Billion |
| Other Investing Activities | -528 Million | -1 Million | -163 Million | -171 Million | -5.51 Billion | -346 Million |
| Financing Cash Flow | -5.12 Billion | -6.46 Billion | -8.87 Billion | 770 Million | -7.63 Billion | -12.31 Billion |
| Debt repayment | -2.25 Billion | -1.5 Billion | -4.75 Billion | -2.5 Billion | -2.75 Billion | -6.25 Billion |
| Dividends payments | -3.8 Billion | -3.7 Billion | -3.6 Billion | -3.44 Billion | -3.22 Billion | -2.97 Billion |
| Common Stock Repurchased | -1 Billion | -1.39 Billion | -546 Million | -1.58 Billion | -1.74 Billion | -2.9 Billion |
| Common Stock Issuance | 232 Million | 309 Million | 169 Million | 256 Million | 209 Million | 289 Million |
| Other Financing Activities | 1.7 Billion | -173 Million | -145 Million | 8.04 Billion | -122 Million | -486 Million |
| Accounts receivables | 157 Million | -406 Million | 313 Million | -1.17 Billion | -218 Million | 480 Million |
| Accounts payables | -347 Million | 226 Million | -118 Million | 80 Million | -61 Million | -39 Million |
| Inventory | -842 Million | -310 Million | 11 Million | -195 Million | -95 Million | -310 Million |
| Other working capital | -1.27 Billion | -1.27 Billion | 283 Million | -352 Million | -424 Million | -1.07 Billion |
| Cash at beginning of period | 5.41 Billion | 5.33 Billion | 5.99 Billion | 11.63 Billion | 17.94 Billion | 7.58 Billion |
| Cash at end of period | 6.08 Billion | 5.41 Billion | 5.33 Billion | 5.99 Billion | 11.63 Billion | 17.94 Billion |
| Capital Expenditure | -585 Million | -728 Million | -579 Million | -650 Million | -825 Million | -924 Million |
| Effect of forex changes on cash | 57 Million | -63 Million | -35 Million | 43 Million | -2 Million | -85 Million |
| Net cash flow / Change in cash | 673 Million | 74 Million | -659 Million | -5.63 Billion | -6.3 Billion | 10.35 Billion |
| Free Cash Flow | 7.42 Billion | 8.34 Billion | 10.8 Billion | 7.51 Billion | 8.31 Billion | 7.47 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.61 Billion | -4.17 Billion | 1.41 Billion | 5.61 Billion | 2.17 Billion | 1.03 Billion |
| Depreciation & Amortization | 694 Million | 690 Million | 688 Million | 2.69 Billion | 684 Million | 681 Million |
| Deferred income taxes | -166 Million | -723 Million | -370 Million | -962 Million | -68 Million | -221 Million |
| Stock-based compensation | 210 Million | 187 Million | 201 Million | 766 Million | 202 Million | 198 Million |
| Change in working capital | -1.54 Billion | -459 Million | -543 Million | -2.3 Billion | -1.54 Billion | 331 Million |
| Other non-cash items | 2.29 Billion | 8.3 Billion | 776 Million | 2.19 Billion | 315 Million | 309 Million |
| Investing Cash Flow | -307 Million | -2.2 Billion | -727 Million | -2.26 Billion | -229 Million | -483 Million |
| Investments in PPE | -130 Million | -105 Million | -215 Million | -585 Million | -122 Million | -139 Million |
| Acquisitions | -152 Million | -4.04 Billion | -279 Million | -1.15 Billion | -79 Million | -243 Million |
| Investment purchases | -34 Million | -654 Million | -680 Million | -2.37 Billion | -395 Million | -645 Million |
| Sales/Maturities of investments | - | 2.59 Billion | 447 Million | 1.84 Billion | 361 Million | 545 Million |
| Other Investing Activities | 7 Million | 5 Million | -233 Million | -528 Million | 6 Million | -1 Million |
| Financing Cash Flow | -2.95 Billion | -1.36 Billion | -1.09 Billion | -5.12 Billion | -1.51 Billion | -1.1 Billion |
| Debt repayment | -1.85 Billion | - | -1 Million | -2.25 Billion | -2.25 Billion | -1.06 Billion |
| Dividends payments | -972 Million | -990 Million | -943 Million | -3.8 Billion | -953 Million | -944 Million |
| Common Stock Repurchased | -100 Million | -400 Million | -150 Million | -1 Billion | -300 Million | -150 Million |
| Common Stock Issuance | 5 Million | 146 Million | 26 Million | 232 Million | 83 Million | 26 Million |
| Other Financing Activities | -36 Million | -116 Million | -31 Million | 1.7 Billion | 1.9 Billion | 1.03 Billion |
| Accounts receivables | -29 Million | -66 Million | 220 Million | 157 Million | -612 Million | -86 Million |
| Accounts payables | -83 Million | 72 Million | -43 Million | -347 Million | -29 Million | -3 Million |
| Inventory | -70 Million | -45 Million | -307 Million | -842 Million | -82 Million | -226 Million |
| Other working capital | -1.36 Billion | -420 Million | -413 Million | -1.27 Billion | -826 Million | 646 Million |
| Cash at beginning of period | 4.71 Billion | 6.08 Billion | 5.7 Billion | 5.41 Billion | 5.7 Billion | 4.93 Billion |
| Cash at end of period | 2.77 Billion | 4.71 Billion | 6.08 Billion | 6.08 Billion | 5.7 Billion | 5.7 Billion |
| Capital Expenditure | -130 Million | -105 Million | -215 Million | -585 Million | -122 Million | -139 Million |
| Effect of forex changes on cash | -11 Million | -18 Million | 37 Million | 57 Million | -7 Million | 14 Million |
| Net cash flow / Change in cash | -1.94 Billion | -1.36 Billion | 380 Million | 673 Million | 1 Million | 768 Million |
| Free Cash Flow | 1.19 Billion | 2.11 Billion | 1.95 Billion | 7.42 Billion | 1.63 Billion | 2.19 Billion |
DOLE
AME
OVB
ORDS
FOG
9978